Research Article
[Retracted] Application of Nanoparticles in Diagnosis and Treatment of Pancreatic Cancer
Table 1
Comparison of general data and results before operation between the two groups.
| Index classification | Nanocomposite artificial tube group | Nylon tube group | t value | value |
| Age | ≥60 | 11 (36.67%) | 13 (43.33%) | 7.654 | 0.348 | <60 | 19 (63.33%) | 17 (56.67%) | 6.325 | 0.631 |
| Gender | Male | 16 (53.335) | 18 (60%) | 4.367 | 0.534 | Female | 14 (46.67%) | 12 (40%) | 7.148 | 0.324 |
| Hypertension | 10 (33.33%) | 11 (36.67%) | 6.358 | 0.897 | Diabetes | 6 (20%) | 8 (26.675) | 5.541 | 0.547 | Preoperative jaundice | 5 (16.67%) | 6 (20%) | 5.327 | 0.657 |
| Preoperative albumin (g/L) | ≥30 | 27 (90%) | 29 (96.67%) | 7.364 | 0.357 | <30 | 3 (10%) | 1 (3.33%) | 6.396 | 0.571 |
| Total bilirubin (μmol/L) | ≥200 | 3 (10%) | 5 (16.67%) | 6.365 | 0.368 | <200 | 27 (90%) | 25 (83.33%) | 7.219 | 0.589 |
|
|